More about

Adjuvant Chemotherapy

News
April 03, 2020
2 min read
Save

Younger women with gynecologic cancers at high risk for osteoporosis 1 year after treatment

Younger women with gynecologic cancers at high risk for osteoporosis 1 year after treatment

Women aged 65 years or younger who underwent surgery and adjuvant chemotherapy for gynecologic cancer appeared at higher risk for osteopenia and osteoporosis as early as 1 year after treatment, according to study results presented at the virtual Society of Gynecologic Cancer Annual Meeting.

News
March 18, 2020
3 min read
Save

Neoadjuvant chemotherapy may not expedite treatment for breast cancer

Neoadjuvant chemotherapy may not expedite treatment for breast cancer

Neoadjuvant chemotherapy did not appear to expedite treatment compared with adjuvant chemotherapy for women with breast cancer, according to study findings published in Cancer Medicine.

News
February 17, 2020
3 min read
Save

Single adjuvant chemotherapy course safe, effective for high-risk testicular cancer

A single course of adjuvant bleomycin, etoposide and cisplatin chemotherapy appeared safe and effective among a cohort of men with high-risk primary testicular cancer, according to results of the phase 3, single-arm, prospective 111 study published in European Urology.

News
December 19, 2019
2 min read
Save

ACA leads to earlier diagnosis, better care for young adults with colorectal cancer

ACA leads to earlier diagnosis, better care for young adults with colorectal cancer

The Affordable Care Act’s dependent coverage expansion provision has resulted in earlier-stage diagnosis and more timely receipt of adjuvant chemotherapy among young patients with colorectal cancer, according to results of a retrospective study published in Journal of the National Cancer Institute.

News
August 23, 2019
2 min read
Save

Early reductions in adjuvant chemotherapy dose may impact breast cancer survival

Early adjuvant chemotherapy dose reductions appeared to adversely affect survival outcomes among women with intermediate- or high-risk breast cancer, according to results of a retrospective study published in Journal of the National Comprehensive Cancer Network.

News
July 25, 2019
3 min read
Save

Erdafitinib appears effective for locally advanced, metastatic urothelial carcinoma

Erdafitinib appears effective for locally advanced, metastatic urothelial carcinoma

Erdafitinib induced a high rate of objective tumor response in patients with locally advanced and unresectable or metastatic urothelial carcinoma with FGFR alterations, according to results of a single-arm phase 2 study published in The New England Journal of Medicine.

News
August 22, 2023
2 min watch
Save

VIDEO: Treatment options for endometrial cancer

VIDEO: Treatment options for endometrial cancer

  Healio spoke to Kevin M. Elias, MD, director of the Gynecologic Oncology Laboratory at Brigham and Women's Hospital and assistant professor of obstetrics, gynecology and reproductive biology at Harvard Medical School, about screening for endometrial cancer.

View more